CN111606949A
|
|
Preparation method of fosaprevir impurity
|
CN110981911A
|
|
Preparation method of tenofovir alafenamide
|
CN110272455A
|
|
A kind of half fumaric acid tenofovir Chinese mugwort draws the preparation method of phenol amine key intermediate
|
CN108913729A
|
|
A kind of enzyme reducing preparation method of Nebivolol Intermediates
|
CN108383822A
|
|
The preparation method of the chloro- 1- of 2- (the fluoro- 3,4- dihydros -2H-1- chromenes -2- bases of 6-) ethyl ketone
|
CN105153231A
|
|
Preparation method of phenyl PMPA
|
CN105111163A
|
|
Synthesis method of 4-(4-aminophenyl)-3-morpholone
|
CN105130976A
|
|
Method for synthesizing rivaroxaban intermediate
|
CN104193762A
|
|
Method of preparing benzene sulfonic acid clopidogrel crystal form III
|
CN103772275A
|
|
Montelukast di(n-propyl) amine salt crystal form and preparation method and application thereof
|
CN103570618A
|
|
Preparation method of montelukast sodium
|
CN103467469A
|
|
Separation method of triacetyl ganciclovir isomer
|
CN103059023A
|
|
Method for preparing ganciclovir crystal form II
|
CN103193778A
|
|
Preparation methods of N-alkyl valaciclovir compound and its hydrochloride and intermediate
|
CN101812090A
|
|
Preparation method of adefovir monoester
|
CN101781333A
|
|
Adefovir dipivoxil crystal form and preparation method thereof
|
CN101723829A
|
|
Method for synthesizing acecloguanosine lateral chain
|
CN102070635A
|
|
Preparation method for ganciclovir valine ester derivative
|
CN101602764A
|
|
Method for preparing acyclovir 2/3 hydrate
|
CN101402559A
|
|
Purification method for D, L-naproxen
|